Table 5 Plasma Total Cholesterol, LDL cholesterol and HDL cholesterol levels: effectiveness of treatments
Time (weeks) | % Change | |||
|---|---|---|---|---|
Variable | Group | Initial | 8 | 8 weeks - Initial |
Total Cholesterol (mg/dl) | Placebo | 211.16 ± 11.92 | 206.68 ± 20.19 | -2.12 |
Formula A (↓ dose) | 208.74 ± 10.49 | 171.17 ± 18.82a | -18.00† | |
Formula B (↑ dose) | 210.64 ± 9.30 | 152.75 ± 10.19b | -27.48‡ | |
LDL Cholesterol (mg/dl) | Placebo | 166.21 ± 9.25 | 162.63 ± 17.83 | -2.39 |
Formula A (↓ dose) | 163.94 ± 8.27 | 139.91 ± 8.92a | -14.66† | |
Formula B (↑ dose) | 165.84 ± 7.29 | 133.05 ± 7.71b | -19.77‡ | |
HDL Cholesterol (mg/dl) | Placebo | 35.92 ± 5.16 | 37.22 ± 5.59 | +3.62 |
Formula A (↓ dose) | 34.72 ± 3.28 | 39.46 ± 4.48a | +13.65† | |
Formula B (↑ dose) | 32.43 ± 2.10 | 38.63 ± 3.11b | +19.12‡ | |